vh2022
  • Home
    • About
    • 2022 Committee
    • Privacy Policy
    • Environmental Policy
  • Register
    • Registration Rates
    • Why register
    • Terms & Conditions
    • Accommodation
    • Venue & Location
    • COVID-19 Information
  • Program
    • 2022 Program
    • 2022 Poster Listing
    • Abstract Submission
    • Associated Events
  • Speakers
    • Keynote Speakers 2022
    • Speaker Presentation Assistance
  • Sponsorship
    • Sponsors
    • Why Sponsor
  • Scholarship Opportunities
  • Contact Us
  • Digital Toolkit
  • VH2021 Conference
  • Search
  • Menu Menu
  • Twitter
  • Facebook

Viral Hep 2022

ON DEMAND

ABSTRACT

PROGRAM

Join Our Mailing List

KEY DEADLINES



Abstract Submission Deadline: CLOSED


Early Bird Registration Deadline: CLOSED


Accommodation Deadline: CLOSED


Standard Registration Deadline: CLOSED

REGISTER

The committee are pleased to announce the ON DEMAND VIRTUAL Abstract Program is now available.

The ON DEMAND VIRTUAL Program will be available to access from the start of the conference, Sunday 30 May 2021. The pre-recorded presentations are available in the On Demand section of the Virtual Portal and can be watched at your leisure. Why not design your own program and add them to your calendar!

Biomedical & Clinical Oral Abstract Presentations

#085 Contribution of General Practitioners in Hepatitis C Treatment in Australia: Experience of an Unrestricted Model of Direct-Acting Antiviral Treatment Program

Speaker: Behzad Hajarizadeh, The Kirby Institute, UNSW Sydney, NSW

#090 Effectiveness of Sofosbuvir/Velpatasvir (SOF/VEL) in patients with chronic hepatitis (HCV) infection and psychiatric disorders: real-world care management from 6 countries.

Speaker: Mary Fenech, QuIHN, QLD

#053 Focus: Focus on HCV Elimination in Community Settings (Community Based OST Dispensing Pharmacies) Via a Mobile Clinic

Speaker: Kristen McKee, Western Sydney LHD, NSW

#050 Functional Cure of Chronic Hepatitis B is Associated with Co-Occurrence of HBSAG/Anti-HBS Immune Complex Peaks with Alt Flares, and Seroconversion to Potently Neutralising Anti-HBS

Speaker: Hui Xu, Victorian Infection Diseases Reference Laboratory at Doherty Institute, VIC

#136 Hepatitis C Point of Care Testing – Implementation Learnings and Early Results from QuIHN NSP’s

Speaker: Amanda Kvassay, QuIHN, QLD

#135 Hepatitis C Testing and Treatment in NSP Settings – A QuIHN Perspective

Speaker: Amanda Kvassay, QuIHN, QLD

#012 DRIED BLOOD SPOT (DBS) TESTING PILOT – Client-centred testing and treatment (or reaching the high hanging fruit)

Speaker: Nigel Carrington, Sydney Sexual Health Centre, NSW

#091 Hepatitis C Virus (HCV) Elimination in People Who Inject Drugs (PWID): Sofosbuvir/Velpatasvir (SOF/VEL) as a Simple Tool to Implement a Test and Treat Approach in this Vulnerable Population

Speaker: Joss O’Loan, Kombi Clinic, QLD

#024 Community-Based Care for Viral Hepatitis – A Survey of General Practitioners’ Perspectives in Brisbane, Australia

Speaker: Belaynew Taye, The University of Queensland, QLD

#126 Diagnostic Accuracy of Assays Using Finger-Stick Capillary and Dried Blood Spot Samples for Determination of Hepatitis C RNA Detection: A Systematic Review and Meta-Analysis

Speaker: Beth Catlett, The Kirby Institute, UNSW Sydney, NSW

#076 Hepatitis in Prison Elimination Program Video: Highlighting Contribution of People in Custody to Elimination Efforts

Speaker: Tracey Brown, Justice Health And Forensic Mental Health Network, NSW

Epidemiology & Public Health Oral Abstract Presentations

#048 Hepatitis C Virus Reinfection Following Direct Acting Antiviral Treatment in the Prison Setting: The Stop-C Study

Speaker: Joanne Carson, The Kirby Institute, UNSW Sydney, NSW

#105 Hepatitis C Reinfection Risk Following Successful Therapy Among People Living with HIV: A Global Systematic Review, Meta-Analysis, and Meta-Regression

Speaker: Samira Hosseini-Hooshyar, The Kirby Institute, UNSW Sydney, NSW

#031 A Guide to Scale-Up of Testing and Treatment for Hepatitis C in the Prison Setting: The Stop-C Implementation Toolkit

Speaker: Marianne Byrne, The Kirby Institute, UNSW Sydney, NSW

#082 Assessment of the Cost-Effectiveness of Australia’s Risk-Sharing Agreement for Direct-Acting Antiviral Treatments for Hepatitis C

Speaker: Nick Scott, The Burnet Institute, VIC

#142 The cost-effectiveness of general population testing for hepatitis B in Australia

Speaker: Nick Scott, The Burnet Institute, VIC

#125 Managing Hepatitis B in the Western Desert: The Ngaanyatjarra Health Service Approach

Speaker: David Scrimgeour, Ngaanyatjarra Health Service, SA

#112 Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalised People with Recent Drug Dependence in New South Wales, Australia: A Population-Based Linkage Study

Speaker: Heather Valerio, The Kirby Institute, UNSW Sydney

#084 Efficacy of Harm Reduction and Community Mental Health Staff Testing and Treating Hepatitis C at a Regional Needle and Syringe Program: A Retrospective Cohort Study.

Speaker: Amanda Wade, Barwon Health, VIC

#102 Evaluation of the HCV Cascade of Care Among People with HIV/Hepatitis C Co-Infection in New South Wales, Australia: A Data Linkage Study

Speaker: Samira Hosseini-Hooshyar, The Kirby Institute, UNSW Sydney, NSW

#101 Hepatitis C Virus Antibody Testing Among Opioid Agonist Therapy Recipients, Victoria, Australia, 2012 to 2019

Speaker: Joshua Dawe, The Burnet Institute, VIC

#131 Hepatitis C Virus Reinfection Incidence Among Gay, Bisexual and Other Men who Have Sex with Men Living with HIV Before and After the Availability of Direct Acting Antivirals in Australia

Speaker: Brendan Harney, The Burnet Institute, VIC

#120 Changes in Hepatitis C Testing Among Individuals Attending Primary Care Services Specialising in PWID Services in Victoria, Australia Following COVID-19 Restrictions

Speaker: Michael Traeger, The Burnet Institute, VIC

#072 Association Between Health Service Utilisation and Experiences of Stigma Among People at Risk of, or Living with, Hepatitis C in Melbourne, Australia

Speaker: Filip Djordjevic, The Burnet Institute, VIC

#089 Assessing the Impact of the EC Nurse-Led Model of Care on Hepatitis C (HCV) Testing Coverage in a Network of High Caseload Primary Care Clinics

Speaker: Chloe Layton, The Burnet Institute, VIC

Community & Social Science Oral Abstract Presentations

#044 Strengthening Workforce Capacity to Increase Hepatitis C Testing and Treatment Among Urban Aboriginal and Torres Strait Islander People

Speaker: Linda Selvey, The University of Queensland, QLD

#045 Supercharging the Digital Highway, One Video at a Time

Speaker: Jessie Badger, Hepatitis Queensland, QLD

#088 Correctional Officers and Justice Health Staff Perspectives of Hepatitis C Treatment as Prevention Scale up Within the Prison Setting

Speaker: Lise Lafferty, Centre for Social Research in Health, UNSW Sydney, NSW

#026 The Centre or the Periphery? Social Relationships and Hepatitis C Treatment in the Elimination Era

Speaker: Adrian Farrugia, La Trobe University, VIC

#016 Knowledge and Beliefs about Hepatitis B Virus Infection and Associated Factors Among Chinese Migrants in Australia

Speaker: Defeng Jin, Centre for Social Research in Health, UNSW Sydney, NSW

#100 Delivering Education to Aboriginal and Torres Strait Islander Health Workers and Health Practitioners in an Online Environment

Speaker: Phoebe Schroder, Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, NSW

#079 Barriers to Hepatitis C Testing and Treatment Experienced by Sub-Groups of People who Inject Drugs

Speaker: Jack Gunn, The Burnet Institute, VIC

#096 Hepatitis C Free Cairns: Using Incentives to Increase Access to Hepatitis C Testing and Treatment

Speaker: Joshua Dawe, Burnet Institute

#052 Success of a Non-Clinical Service Offering HIV and Hepatitis C Dried Blood Spot Testing in Community

Speaker: Ana Romero, Sydney Local Health District, NSW

#011 Educating from Inside Out – Learnings from Peer Educators in Townsville Correctional Centre

Speaker: Suzanne Wales, QuIHN, QLD

#095 When Making a Video is More than Point and Shoot

Speaker: Marrianne Black, Ethnic Communities Council of Queensland, QLD

#035 Digital Innovations in Viral Hepatitis and Liver Health During COVID-19

Speaker: Isabelle Purcell, LiverWELL Limited, VIC

#067 Peer Based Advice for People Newly Diagnosed with Hepatitis B

Speaker: Jack Wallace, The Burnet Institute, VIC

#133 Effectiveness of a community outreach program to improve access to FibroScan® for clients with chronic Hepatitis B

Speaker: Jo Durham, Queensland University of Technology, QLD

#109 Creating a National Hepatitis C Health Promotion Campaign for People Who Inject Drugs

Speaker: Emily Adamson, The Burnet Institute, VIC

#147 HepBCommunity.org: a global online forum dedicated to supporting people with hepatitis B

Speaker: Thomas Tu, University Of Sydney And Westmead Institute For Medical Research, NSW

#040 Pandemic Preparedness: The Future of Workforce Development Programs on Viral Hepatitis and Liver Health

Speaker: Pearl Prabal, LiverWELL Limited, VIC

#042 Community Outreach Nurse Project – Why Everyone Still Needs a Nurse

Speaker: Jeannette Tibbs, Hepatitis Queensland, QLD

#110 Assessing the Impact of a Hepatitis C Testing Initiatives Program – A Method to Expand Our Collaborative Peer Based Model of Care

Speaker: Leanne Myers, Peer Based Harm Reduction WA

#033 Health Literacy and Hepatitis C Education in Australian Prisons: A National Needs Assessment

Speaker: Yumi Sheehan, The Kirby Institute, UNSW Sydney, NSW

#132 Challenges of Getting People Tested and Treated – Perspectives from a Peer Harm Reduction Worker

Speaker: Esha Leyden, QuIHN, QLD

#065 Identifying Enablers to Integrating Hepatitis C into Primary Care Nurses’ Scope of Practice

Speaker: Jacqui Richmond, The Burnet Institute, VIC

We acknowledge that ASHM offices are located on the land of the Gadigal peoples of the Eora Nation (Sydney Office) and the Turrbal and Jagera/Yuggera peoples (Brisbane Office) who are the Traditional Owners of the lands where both offices are situated. We pay our respects to Elders past and present.


Copyright 2020 by ASHM Conference & Events Division
Scroll to top